Alder Biopharmaceuticals

Arena Pharma's R&D lead quits 6 months into the job, replaced by Alder CMO
Fierce Biotech
Tue, 12/1/20 - 10:49 am
Arena Pharmaceuticals
R&D
Alder Biopharmaceuticals
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Alder's migraine drug attracted plenty of dealmakers. The company, not so much
Biopharma Dive
Wed, 09/25/19 - 09:17 am
Alder Biopharmaceuticals
M&A
Lundbeck
Alder won’t solve Lundbeck’s headaches
EP Vantage
Mon, 09/16/19 - 05:12 pm
Lundbeck
M&A
Alder Biopharmaceuticals
migraines
Lundbeck pens $2B Alder takeover to boost brain disease pipeline
Fierce Biotech
Mon, 09/16/19 - 09:23 am
Lundbeck
Alder Biopharmaceuticals
M&A
Alder BioPharmaceuticals approaches rare status for a Seattle biotech
Bizjournals
Sat, 08/17/19 - 01:33 pm
Alder Biopharmaceuticals
Seattle
migraines
These 6 biotech stocks are promising takeover targets
Marketwatch
Thu, 05/2/19 - 11:33 am
M&A
Sarepta Therapeutics
Amarin
Intercept Pharmaceuticals
Immunomedics
Alder Biopharmaceuticals
Biogen
Faint hope for Alder as Teva bucks dismal migraine trend
EP Vantage
Thu, 05/2/19 - 11:12 am
migraines
Alder Biopharmaceuticals
Teva
Eli Lilly
Amgen
Emgality
Ajovy
eptinezumab
Why Alder thinks its late-comer migraine drug can succeed
Biopharma Dive
Thu, 04/11/19 - 12:28 pm
Alder Biopharmaceuticals
migraines
eptinezumab
Teva, Alder ink migraine deal to avoid legal headache
Biopharma Dive
Tue, 01/9/18 - 10:53 pm
Teva Pharmaceutical
Alder Biopharmaceuticals
migraines
eptinezumab
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
New phase 2 data boosts prospects for Alder's migraine drug
BioPharma Dive
Mon, 03/28/16 - 06:51 pm
migraines
Alder Biopharmaceuticals
ALD403
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
FDA
Rayaldee
OPKO Health
Nuplazid
Acadia
abaloparatide
Radius Health
pegvaliase
Biomarin
ALD403
Alder Biopharmaceuticals
IPO Stock Watch: Alder Soars On Migraine Drug Results
Investors.com
Sat, 05/16/15 - 02:02 pm
IPOs
Alder Biopharmaceuticals
migraines
ALD403
IPO Preview: Alder Biopharmaceuticals
Seeking Alpha
Wed, 05/7/14 - 06:29 pm
IPOs
Alder Biopharmaceuticals
3 Companies Working to Make Migraines Milder
Motley Fool
Wed, 08/7/13 - 09:36 am
migraines
Allergan
Botox
LY2951742
Eli Lilly
Arteaus Therapeutics
Merck
MK-1602
Alder Biopharmaceuticals
ALD403
Bristol-Myers Squibb